KineMed, CHDI Foundation Extend Huntington's Disease Collaboration | GenomeWeb

NEW YORK (GenomeWeb) – KineMed and CHDI Foundation today said they are extending their collaboration to characterize and track the pathogenesis of Huntington's disease and to evaluate possible therapeutic interventions.

The collaboration leverages KineMed's translational biomarker platform, which is based on the use of mass spectrometry and mass spectroscopy and interrogates the kinetics of biochemical processes of an entire living organism.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.